1
|
Sakr G, Sartel C, Sallet V, Lusson A, Patriarche G, Galtier P, Barjon J. Surface effects on exciton diffusion in non polar ZnO/ZnMgO heterostructures. J Phys Condens Matter 2017; 29:485706. [PMID: 29120866 DOI: 10.1088/1361-648x/aa8a03] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
The diffusion of excitons injected in ZnO/Zn0.92Mg0.08O quantum well heterostructures grown by metal-organic-vapor-phase-epitaxy on non-polar ZnO substrates is investigated at room temperature. Cathodoluminescence linescans in a field-emission-gun scanning-electron-microscope are performed across cleaved cross-sections. A 55 nm diffusion length is assessed for excitons in bulk ZnMgO. When prepared as small angle bevels using focused ion beam (FIB), the effective diffusion length of excitons is shown to decrease down to 8 nm in the thinner part of the slab. This effect is attributed to non-radiative surface recombinations, with a 7 × 104 cm s-1 recombination velocity estimated at the FIB-machined ZnMgO surface. The strong reduction of the diffusion extent in such thin lamellae usually used for transmission electron microscopy could be use improve the spatial resolution of cathodoluminescence images, often limited by diffusion processes.
Collapse
Affiliation(s)
- G Sakr
- GEMaC, Université de Versailles St Quentin en Yvelines, CNRS, Université Paris-Saclay, 45 avenue des Etats-Unis, 78035 Versailles Cedex, France
| | | | | | | | | | | | | |
Collapse
|
2
|
Pratt I, Aguilar F, Dusemund B, Galtier P, Gott D, Larsen J, Parent-Massin D, Rietjens I. Re-evaluation of synthetic colours: State of the art. Toxicol Lett 2011. [DOI: 10.1016/j.toxlet.2011.05.1026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
3
|
Sussiau M, Encinas A, Nguyen Van Dau F, Vaurès A, Schuhl A, Galtier P. Magnetization Reversal by Rotation in Magnetic Thin Films Deposited on Step Bunched Si(111) Substrates. ACTA ACUST UNITED AC 2011. [DOI: 10.1557/proc-475-195] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
ABSTRACTMagnetic and magnetoresistive properties of magnetic thin films deposited on periodically structured substrates have been studied. By using a thermodynamical heat treatment, we activate the step bunching phenomenon on vicinal Si(111) substrates misoriented towards [112] which results in a laterally modulated surface with a period around 0.1 μm. Epitaxial magnetic thin films deposited on these substrates exhibit an in-plane uniaxial anisotropy and a specific magnetoresistive behavior which characterizes the magnetization reversal process. In this contribution, we demonstrate that these properties can also be observed in non-epitaxial structures grown either by molecular beam epitaxy or by sputtering. In particular, magnetotransport measurements show that by varying parameters such as the nature of the magnetic metal, the layer thickness or the strength of the induced anisotropy, we can modulate the interplay between the anisotropy and the exchange stiffness, and, consequently, observe gradual magnetization reversal behaviors between a Stoner-Wohlfarth uniform mode and a non-uniform mode.
Collapse
|
4
|
Scholz F, HÄrle V, Steuber F, Sohmer A, Bolay H, Syganow V, DÖrnen A, Im JS, Hangleiter A, Duboz JY, Galtier P, Rosencher E, Ambacher O, Brunner D, Lakner H. Metalorganic vapor phase epitaxial growth of GaInN/GaN hetero structures and quantum wells. ACTA ACUST UNITED AC 2011. [DOI: 10.1557/proc-449-3] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
ABSTRACTGaInN/GaN heterostructures and quantum wells have been grown by low pressure metalorganic vapor phase epitaxy on sapphire using an AIN nucleation layer. We found a significant In incorporation only for growth temperatures of 700°C, although still very high In/Ga ratios in the gas phase had to be adjusted. The In content could be increased by reducing the H2/N2 flow ratio in the main carrier gas. GaInN layers typically show two lines in low temperature photoluminescence which are identified as excitonic-like (high energy peak) and impurity-related-like (low energy) by time-resolved spectroscopy. Quantum wells with a thickness between 8 and 0.5 nm showed only one emission line. The peak of the thinnest wells shows excitonic-like behaviour, whereas we found a smooth transition to an impurity-related-like type with increasing thickness. By scanning transmission electron microscopy studies we found indications for composition fluctuations in these thicker quantum wells which may cause localization effects for the excitons and thus be responsible for the observed optical spectra.
Collapse
|
5
|
|
6
|
Quintana-Solórzano R, Thybaut J, Galtier P, Marin G. Simulation of an industrial riser for catalytic cracking in the presence of coking using Single-Event MicroKinetics. Catal Today 2010. [DOI: 10.1016/j.cattod.2009.07.110] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
7
|
Meissonnier G, Raymond I, Laffitte J, Cossalter A, Pinton P, Benoit E, Bertin G, Galtier P, Oswald I. Dietary glucomannan improves the vaccinal response in pigs exposed to aflatoxin B1 or T-2 toxin. WORLD MYCOTOXIN J 2009. [DOI: 10.3920/wmj2008.1127] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
The aim of the study was to investigate whether dietary supplementation with yeast-derived glucomannan protects pigs against the deleterious effects that exposure to aflatoxin B1 (AFB1) or T-2 toxin has on the vaccinal immune response and drug-metabolising enzymes. Three doses of pure mycotoxin (AFB1 trial: 482, 968 and 1,912 µg/kg feed; T-2 toxin trial: 593, 1,155 and 2,067 µg/kg feed) with or without dietary glucomannan supplementation (2 g/ kg feed) were tested in weaned pigs for 28 days. At days 4 and 15 pigs were immunised with ovalbumin to study the humoral and cell-mediated antigen-specific immune responses. The effects of AFB1 and T-2 toxin intake alone in pigs have already been published. In all parameters investigated no differences were apparent between animals receiving the unsupplemented control diet or the control diet containing glucomannan. In the AFB1 trial glucomannan decreased the severity of liver lesions in animals exposed to 968 µg/kg feed. Exposure to both AFB1 and T-2 toxin were associated with impaired phase I liver enzyme activities, but glucomannan demonstrated a limited protective effect on these enzymes. With regard to the immune defence system, both toxins modulated the vaccinal immune response; AFB1 impaired specific cellular response and T-2 toxin the specific humoral response. Glucomannan supplementation restored the ovalbumin-specific lymphocyte proliferation that was delayed in pigs exposed to AFB1, regardless of dose. In the T-2 toxin trial glucomannan supplementation restored anti-ovalbumin immunoglobulin G production, which was significantly reduced in pigs exposed to both medium and high doses of the toxin. In conclusion, glucomannan dietary supplementation demonstrated no deleterious effects in control animals and protective effects against AFB1 and T-2 toxin immunotoxicity during a vaccinal protocol.
Collapse
Affiliation(s)
- G. Meissonnier
- Laboratoire de Pharmacologie-Toxicologie UR-66, INRA, 180 Chemin de Tournefeuille, BP 93173, 31027 Toulouse Cedex 3, France
- Alltech-France, 14 Place Marie-Jeanne Bassot, 92300 Levallois-Perret cedex, France
| | - I. Raymond
- École Nationale Vétérinaire de Toulouse, BP 87614, 31076 Toulouse Cedex 3, France
| | - J. Laffitte
- Laboratoire de Pharmacologie-Toxicologie UR-66, INRA, 180 Chemin de Tournefeuille, BP 93173, 31027 Toulouse Cedex 3, France
| | - A. Cossalter
- Laboratoire de Pharmacologie-Toxicologie UR-66, INRA, 180 Chemin de Tournefeuille, BP 93173, 31027 Toulouse Cedex 3, France
| | - P. Pinton
- Laboratoire de Pharmacologie-Toxicologie UR-66, INRA, 180 Chemin de Tournefeuille, BP 93173, 31027 Toulouse Cedex 3, France
| | - E. Benoit
- École Nationale Vétérinaire de Lyon, 1 Avenue Bourgelat, 69280, Marcy-l'Étoile, France
| | - G. Bertin
- Alltech-France, 14 Place Marie-Jeanne Bassot, 92300 Levallois-Perret cedex, France
| | - P. Galtier
- Laboratoire de Pharmacologie-Toxicologie UR-66, INRA, 180 Chemin de Tournefeuille, BP 93173, 31027 Toulouse Cedex 3, France
| | - I. Oswald
- Laboratoire de Pharmacologie-Toxicologie UR-66, INRA, 180 Chemin de Tournefeuille, BP 93173, 31027 Toulouse Cedex 3, France
| |
Collapse
|
8
|
Baron T, Hazlett JD, Bergougnou MA, Briens CL, Galtier P. Size distribution of the particles entrained from fluidized beds: Gas humidity effects. CAN J CHEM ENG 2009. [DOI: 10.1002/cjce.5450700403] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
9
|
Meissonnier G, Laffitte J, Raymond I, Benoit E, Cossalter AM, Pinton P, Bertin G, Oswald I, Galtier P. Subclinical doses of T-2 toxin impair acquired immune response and liver cytochrome P450 in pigs. Toxicology 2008; 247:46-54. [DOI: 10.1016/j.tox.2008.02.003] [Citation(s) in RCA: 57] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2007] [Revised: 02/05/2008] [Accepted: 02/06/2008] [Indexed: 10/22/2022]
|
10
|
Cauvin S, Braunschweig B, Galtier P, Glaize Y. Alexip: an Expert System Coupled with a Dynamic Simulator for the Supervision of the Alphabutol Process. ACTA ACUST UNITED AC 2006. [DOI: 10.2516/ogst:1992028] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
11
|
Gouze ME, Laffitte J, Dedieu G, Galinier A, Thouvenot JP, Oswald IP, Galtier P. Individual and combined effects of low oral doses of deoxynivalenol and nivalenol in mice. Cell Mol Biol (Noisy-le-grand) 2005; 51 Suppl:OL809-17. [PMID: 16375817] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2005] [Accepted: 05/23/2005] [Indexed: 05/05/2023]
Abstract
Deoxynivalenol (DON) and nivalenol (NIV) are toxic Fusarium secondary trichothecene metabolites that often co-occur regularly in cereal grains. These compounds were compared for their toxicity towards C57BL/6 mice on several parameters including alteration in plasma biochemistry, immune system reactivity and hepatic drug metabolism capacity. Mice received individual or combined oral doses of each toxin: 0.071 or 0.355 mg/kg of body weight, administrated three days a week for 4 weeks. Food consumption was altered by the single administration of 0.355 mg/kg of NIV, although no noticeable change of body and organ weights or liver protein contents was detected. NIV administration did cause also significant changes in total CO2 and uric acid concentrations in plasma. Individual toxin exposures led to increases in plasma IgA without no detectable change in the ex vivo production of cytokine by splenocytes. The liver ethoxyresorufin O-deealkylase, pentoxyresorufin O-depenthylase and glutathione S-transferase activities were increased in concert with cytochrome P4501a and P4502b subfamily expression. Administration of combinations of DON and NIV resulted in responses similar to that observed using individual doses of each toxin. However, depending on the ratio of toxin doses and biochemical parameters, some responses could be also additive (plasma IgA and hepatic DCNB conjugation) or synergistic (plasma uric acid).
Collapse
Affiliation(s)
- M E Gouze
- Laboratoire de Pharmacologie-Toxicologie, INRA, 180 Chemin de Tournefeuille, 31931 Toulouse, France
| | | | | | | | | | | | | |
Collapse
|
12
|
Gouze ME, Laffitte J, Rouimi P, Loiseau N, Oswald IP, Galtier P. Effect of various doses of deoxynivalenol on liver xenobiotic metabolizing enzymes in mice. Food Chem Toxicol 2005; 44:476-83. [PMID: 16209902 DOI: 10.1016/j.fct.2005.08.020] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2005] [Revised: 06/16/2005] [Accepted: 08/24/2005] [Indexed: 11/25/2022]
Abstract
DON is one of the major mycotoxic contaminant of cereal grains throughout the world. The purpose of this investigation was to characterize the effects of a range of environmentally relevant doses of DON in mice exposed through a subchronic toxicological assay. Animals received 3 days per week for 4 weeks, 0.014, 0.071, 0.355 or 1.774 mg of toxin/kg b.w. All doses, except 0.014 mg/kg, provoked increases in plasma immunoglobulin A whereas there was no change in plasma biochemical parameters such as alkaline phosphatase, electrolytes or other immunoglobulins. Administration of 0.071 or 0.355 mg/kg doses led to increased liver microsomal pentoxyresorufin depentylase and cytosolic glutathione transferase activities. Examining protein modulation, western blot analyses liver fractions from mice receiving these doses revealed increased levels in both P450 2b, GST alpha and pi isoenzymes without any change in P450 1a expression. A significant competitive inhibition of deoxynivalenol on CDNB conjugation in vitro suggests that the mycotoxin is a putative substrate for glutathione S-transferases. These changes in liver xenobiotic metabolizing enzymes are discussed by considering the structural nature of deoxynivalenol and previous reports on similar effects exerted by other trichothecenes. These results suggest that a subchronic exposure to low doses of deoxynivalenol causes changes in the normal liver metabolism of xenobiotics.
Collapse
Affiliation(s)
- M E Gouze
- Department of Pharmacologie, Laboratoire de Pharmacologie-Toxicologie INRA, 180 Chemin de Tournefeuille, 31931 Toulouse, France
| | | | | | | | | | | |
Collapse
|
13
|
Rzepka E, Laroche JM, Teukam Z, Franc G, Jomard F, Ballutaud D, Galtier P. Estimation of the silicon concentration by an optical way in polycrystalline CVD diamond. ACTA ACUST UNITED AC 2004. [DOI: 10.1002/pssa.200405169] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
14
|
Rommeluère JF, Svob L, Jomard F, Mimila-Arroyo J, Amiri G, Lusson A, Sallet V, Gorochov O, Galtier P, Marfaing Y. Nitrogen acceptors in ZnO films grown by metalorganic vapor phase epitaxy. ACTA ACUST UNITED AC 2004. [DOI: 10.1002/pssc.200304251] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
15
|
Eeckhoutte C, Albo AG, Carletti M, Giaccherino AR, Galtier P, Nebbia C, Dacasto M. Time-dependent variations of drug-metabolising enzyme activities (DMEs) in primary cultures of rabbit hepatocytes. Toxicol In Vitro 2002; 16:375-82. [PMID: 12110275 DOI: 10.1016/s0887-2333(02)00018-8] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
In the present study, time-dependent variations of drug-metabolising enzyme activities (DMEs) in primary cultures of rabbit hepatocytes, a species of economic importance in Mediterranean countries, were investigated. Cross-bred rabbits were anesthetised and their livers perfused in situ by a two-step collagenase technique; cells suspensions were filtered, seeded in collagen-coated dishes and cultivated at 37 degrees C in a controlled atmosphere for 24 and 72 h. Cytochrome P450 and b(5) contents as well as the catalytic activity of some P450-dependent monooxygenases were measured in subcellular fractions obtained by differential ultracentrifugation; microsomal proteins were also subjected to immunoblotting, using antibodies to rat P4501A, 2B, 2E1 and 3A isoforms. The activity of some microsomal hydrolytic enzymes was also determined. As regards conjugative enzymes, glutathione content and activities of glutathione S-transferase, uridindiphosphoglucuronosyl-transferase, acetyl-transferase and 1,2-epoxibuthane glutathione transferase were assayed. An overall reduction of the catalytic activity was observed 72 h after plating, reaching in certain instances the level of statistical significance. On the whole, our data confirm those previously reported with hepatocytes obtained from other species; however, the evidence that DMEs were still measurable after 72 h supports the usefulness of this in vitro method for drug metabolism studies in the rabbit as well.
Collapse
Affiliation(s)
- C Eeckhoutte
- Institut Nationale de la Recherche Agronomique, Laboratoire de Pharmacologie et Toxicologie, UR66, 180 chemin de Tournefeuille, St. Martin du Touch, BP 3, 31931 Toulouse cedex, France
| | | | | | | | | | | | | |
Collapse
|
16
|
Burkhardt T, Verstraete J, Galtier P, Kraume M. Residence time distributions with a radiotracer in a hydrotreating pilot plant: Upflow versus downflow operation. Chem Eng Sci 2002. [DOI: 10.1016/s0009-2509(02)00091-x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
17
|
Blanchin S, Galtier P, Kasztelan S, Kressmann S, Penet H, Pérot G. Kinetic Modeling of the Effect of H2S and of NH3 on Toluene Hydrogenation in the Presence of a NiMo/Al2O3 Hydrotreating Catalyst. Discrimination between Homolytic and Heterolytic Models. J Phys Chem A 2001. [DOI: 10.1021/jp011352a] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- S. Blanchin
- Laboratoire de Catalyse en Chimie organique, Faculté des Sciences de l’Université de Poitiers, 40 avenue du recteur Pineau, 86022 Poitiers Cedex, France, Institut Français du Pétrole Solaize, BP 3, 69390 Vernaison, France, and Institut Français du Pétrole, 1 et 4 avenue de bois préau, 92852 Rueil-Malmaison Cedex, France
| | - P. Galtier
- Laboratoire de Catalyse en Chimie organique, Faculté des Sciences de l’Université de Poitiers, 40 avenue du recteur Pineau, 86022 Poitiers Cedex, France, Institut Français du Pétrole Solaize, BP 3, 69390 Vernaison, France, and Institut Français du Pétrole, 1 et 4 avenue de bois préau, 92852 Rueil-Malmaison Cedex, France
| | - S. Kasztelan
- Laboratoire de Catalyse en Chimie organique, Faculté des Sciences de l’Université de Poitiers, 40 avenue du recteur Pineau, 86022 Poitiers Cedex, France, Institut Français du Pétrole Solaize, BP 3, 69390 Vernaison, France, and Institut Français du Pétrole, 1 et 4 avenue de bois préau, 92852 Rueil-Malmaison Cedex, France
| | - S. Kressmann
- Laboratoire de Catalyse en Chimie organique, Faculté des Sciences de l’Université de Poitiers, 40 avenue du recteur Pineau, 86022 Poitiers Cedex, France, Institut Français du Pétrole Solaize, BP 3, 69390 Vernaison, France, and Institut Français du Pétrole, 1 et 4 avenue de bois préau, 92852 Rueil-Malmaison Cedex, France
| | - H. Penet
- Laboratoire de Catalyse en Chimie organique, Faculté des Sciences de l’Université de Poitiers, 40 avenue du recteur Pineau, 86022 Poitiers Cedex, France, Institut Français du Pétrole Solaize, BP 3, 69390 Vernaison, France, and Institut Français du Pétrole, 1 et 4 avenue de bois préau, 92852 Rueil-Malmaison Cedex, France
| | - G. Pérot
- Laboratoire de Catalyse en Chimie organique, Faculté des Sciences de l’Université de Poitiers, 40 avenue du recteur Pineau, 86022 Poitiers Cedex, France, Institut Français du Pétrole Solaize, BP 3, 69390 Vernaison, France, and Institut Français du Pétrole, 1 et 4 avenue de bois préau, 92852 Rueil-Malmaison Cedex, France
| |
Collapse
|
18
|
Dupuy J, Larrieu G, Braun JP, Alvinerie M, Galtier P. Differential effects of phenobarbital on the constitutive and inducible expression of P450 2B and 3A subfamilies in sheep tissues. Can J Physiol Pharmacol 2001; 79:848-53. [PMID: 11697743] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/22/2023]
Abstract
The activity and expression of cytochromes P450 were determined in liver, kidneys, lungs, duodenum, jejunum, ileum, and caecum of adult Lacaune sheep. High expression of total P450, benzphetamine and erythromycin demethylase activities, and P450 2B isoforms, as two distinct proteins that were detected and called P4502 Bm and P4502 Bx, was found in the lungs (in addition to liver). By contrast, the P450 3A subfamily was only expressed in liver and duodenal mucosa of untreated sheep. Phenobarbital (PB) treatment led to significant increases in all measured hepatic parameters and in total P450 of each investigated organ with the exception of ileum and caecum. Benzphetamine demethylase activity increased in liver and kidneys, correlating with the expression of the two P450 2B proteins, which were also induced in duodenum and ileum. By contrast, benzphetamine demethylase activity and expression of the P450 2B isoforms in lungs were unchanged by PB treatment. Erythromycin demethylation activity and P450 3A subfamily expression was increased only in liver of PB-treated sheep.
Collapse
Affiliation(s)
- J Dupuy
- INRA, Laboratoire de Pharmacologie-Toxicologie, Toulouse, France.
| | | | | | | | | |
Collapse
|
19
|
Errouissi F, Alvinerie M, Galtier P, Kerboeuf D, Lumaret JP. The negative effects of the residues of ivermectin in cattle dung using a sustained-release bolus on Aphodius constans (Duft.) (Coleoptera: Aphodiidae). Vet Res 2001; 32:421-7. [PMID: 11592612 DOI: 10.1051/vetres:2001134] [Citation(s) in RCA: 40] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
This paper reports the findings of two trials into the effects of the treatment of cattle with ivermectin slow-release (SR) bolus on the larval development of the dung beetle Aphodius constans Duft. Rectal faecal samples were collected prior to treatment and every 3 and 2 weeks in a first and second trial, respectively, and up to 156 days post-administration of the SR bolus. Faecal ivermectin concentration reached a peak at 63 days post-treatment (1427 ng g(-1)) and ivermectin was detected up to 147 days post-treatment in the first trial (7.2 ng g(-1)). First stage larvae of A. constans were reared with control or contaminated dung and adult beetles were counted after emergence. In the first trial, the comparison of pairwise samples showed that ivermectin prevented the development of larval A. constans until day 105, while at day 135 the rate of emergence was still significantly lower than the corresponding series of control (p < 0.05). In the second trial, the difference between control and treated series remained significant until 143 days post-treatment, with no emergence until 128 days post-administration of SR bolus to cattle. These results show the negative effect of ivermectin on the development of larval A. constans, even at a low concentration (38.4 ng g(-1)). The administration of ivermectin sustained-release bolus to cattle was highly effective in killing dung beetle larvae for approximately 143 days after treatment. The results were similar when dung was obtained from a single animal kept alone, or from a blending of faecal pats obtained from a group of animals kept in field conditions during the whole trial period.
Collapse
Affiliation(s)
- F Errouissi
- Laboratoire de Zoogéographie, Université Paul Valéry-Montpellier 3, France
| | | | | | | | | |
Collapse
|
20
|
Dupuy J, Escudero E, Eeckhoutte C, Sutra JF, Galtier P, Alvinerie M. In vitro metabolism of 14C-moxidectin by hepatic microsomes from various species. Vet Res Commun 2001; 25:345-54. [PMID: 11469506 DOI: 10.1023/a:1010686508307] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Moxidectin is an antiparasitic drug widely used in cattle, sheep and companion animals. No data were available on its metabolism in wild species or in monogastrics. The in vitro metabolism of 14C-moxidectin was studied using hepatic microsomes from several different species: cow (Bos taurus). sheep (Ovis ovis), goat (Capra hircus), deer (Cervus dama), rat (Rattus norvegicus), pig (Sus scrofa and rabbit (Oryctolagus cuniculus). After separation and quantification by HPLC, the extent of metabolism of 14C-moxidectin was greatest with microsomes from sheep (32.7%) as compared to those from cows (20.6%), deer (15.4%), goats (12.7%). rabbits (7.0%) or rats (3.0%). The least metabolism occurred with microsomes from pigs. with 0.8% of total detected metabolites. A C29 monohydroxymethyl metabolite was detected in the greatest amounts. providing 0.4% out of the total detected radioactivity in pigs and 19.3% in sheep. In addition, the importance of P450 3A in the metabolism of 14C-moxidectin was confirmed by using in vivo induced P450 in combination with various P450 inhibitors.
Collapse
Affiliation(s)
- J Dupuy
- INRA-Toulouse, Laboratoire de Pharmacologie-Toxicologie, Tournefeuiille, France
| | | | | | | | | | | |
Collapse
|
21
|
Abstract
A study was undertaken to evaluate and compare faecal excretion of moxidectin and ivermectin in horses after oral administration of commercially available preparations. Ten clinically healthy adult horses, weighing 390-446 kg body weight (b.w.), were allocated to two experimental groups. Group I was treated with an oral gel formulation of moxidectin at the manufacturer's recommended therapeutic dose of 0.4 mg/kg b.w. Group II was treated with an oral paste formulation of ivermectin at the recommended dose of 0.2 mg/kg b.w. Faecal samples were collected at different times between 1 and 75 days post-treatment. After faecal drug extraction and derivatization, samples were analysed by High Performance Liquid Chromatography using fluorescence detection and computerized kinetic analysis. For both drugs the maximum concentration level was reached at 2.5 days post administration. The ivermectin treatment groups' faecal concentrations remained above the detectable level for 40 days (0.6 +/- 0.3 ng/g), whereas the moxidectin treatment group remained above the detectable level for 75 days (4.3 +/- 2.8 ng/g). Ivermectin presented a faster elimination rate than moxidectin, reaching 90% of the total drug excreted in faeces at four days post-treatment, whereas moxidectin reached similar levels at eight days post-treatment. No significant differences were observed for the values of maximum faecal concentration (C(max)) and time of C(max)(T(max)) between both groups of horses, demonstrating similar patterns of drug transference from plasma to the gastrointestinal tract. The values of the area under the faecal concentration time curve were slightly higher in the moxidectin treatment group (7104 +/- 2277 ng.day/g) but were not significantly different from those obtained in the ivermectin treatment group (5642 +/- 1122 ng.day/g). The results demonstrate that although a 100% higher dose level of moxidectin was used, attaining higher plasma concentration levels and more prolonged excretion and gut secretion than ivermectin, the concentration in faeces only represented 44.3+/- 18.0% of the total parental drug administered compared to 74.3 +/- 20.2% for ivermectin. This suggests a higher level of metabolization for moxidectin in the horse.
Collapse
Affiliation(s)
- R Pérez
- Laboratorio de Farmacologia, Facultad Medicina Veterinaria, Universidad de Conception, Chile.
| | | | | | | | | |
Collapse
|
22
|
Abstract
High doses of T-2 toxin are known to decrease protein synthesis and mono-oxygenase activities in rat liver. The purpose of this study was to investigate whether exposure at a low dose could alter the normal metabolism of the xenobiotic by the liver. Three doses of T-2 toxin, dissolved in olive oil, were orally and daily administered to New Zealand white rabbits for five days. At 0.5 mg/kg, three of the five animals died, whereas only a weak decrease in body weight gain and moderate signs of toxicity occurred in rabbits receiving 0.25 mg/kg/day, and the body weight increased without signs of toxicity at 0.1 mg/kg/day. At 0.25 mg/kg/day, total liver microsomal P450 content, and the activities of aminopyrine and benzphetamine N-demethylases, pentoxyresorufin O-depentylase, glutathione S-transferases accepting 1-chloro-2,4-dinitrobenzene and 1,2-dichloro-4-nitrobenzene as substrates, were decreased. By contrast, ethylmorphine and erythromycin N-demethylases, ethoxyresorufin and methoxyresorufin O-dealkylases, aniline hydroxylase, and UDP-glucuronyltransferase accepting p-nitrophenol as substrate, were unaffected. The expression of P450 1A1, 1A2, 2A1, and 2B4, but not P450 2C3 and 3A6, were also decreased, whereas microsomal conjugated dienes, fluorescent substances, and malondialdehyde contents were increased. At 0.1 mg/kg/day, neither significant effects on drug metabolizing enzymes nor microsomal oxidative damages were obtained. Taken together, these results suggest that a short exposure time to the mycotoxin would not be associated with significant changes in the normal metabolism of xenobiotics by the liver.
Collapse
Affiliation(s)
- P Guerre
- Laboratoire de Pharmacie-Toxicologie, E.N.V.T., 23 Chemin des Capelles, 31076 Toulouse, France
| | | | | | | |
Collapse
|
23
|
Coulet M, Eeckhoutte C, Larrieu G, Sutra JF, Alvinerie M, Macé K, Pfeifer A, Zucco F, Stammati AL, De Angelis I, Vignoli AL, Galtier P. Evidence for cytochrome P4501A2-mediated protein covalent binding of thiabendazole and for its passive intestinal transport: use of human and rabbit derived cells. Chem Biol Interact 2000; 127:109-24. [PMID: 10936227 DOI: 10.1016/s0009-2797(00)00167-8] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
Thiabendazole (TBZ), an anthelmintic and fungicide benzimidazole, was recently demonstrated to be extensively metabolized by cytochrome P450 (CYP) 1A2 in man and rabbit, yielding 5-hydroxythiabendazole (5OH-TBZ), the major metabolite furtherly conjugated, and two minor unidentified metabolites (M1 and M2). In this study, exposure of rabbit and human cells to 14C-TBZ was also shown to be associated with the appearance of radioactivity irreversibly bound to proteins. The nature of CYP isoforms involved in this covalent binding was investigated by using cultured rabbit hepatocytes treated or not with various CYP inducers (CYP1A1/2 by beta-naphthoflavone, CYP2B4 by phenobarbital, CYP3A6 by rifampicine, CYP4A by clofibrate) and human liver and bronchial CYP-expressing cells. The covalent binding to proteins was particularly increased in beta-naphthoflavone-treated rabbit cells (2- to 4-fold over control) and human cells expressing CYP1A2 (22- to 42-fold over control). Thus, CYP1A2 is a major isoenzyme involved in the formation of TBZ-derived residues bound to protein. Furthermore, according to the good correlation between covalent binding and M1 or 5OH-TBZ production, TBZ would be firstly metabolized to 5OH-TBZ and subsequently converted to a chemically reactive metabolic intermediate binding to proteins. This metabolic activation could take place preferentially in liver and lung, the main biotransformation organs, rather than in intestines where TBZ was shown to be not metabolized. Moreover, TBZ was rapidly transported by passive diffusion through the human intestinal cells by comparison with the protein-bound residues which were not able to cross the intestinal barrier. Consequently, the absence of toxicity measured in intestines could be related to the low degree of TBZ metabolism and the lack of absorption of protein adducts. Nevertheless, caution is necessary in the use of TBZ concurrently with other drugs able to regulate CYP1A2, particularly in respect to liver and lung tissues, recognised as sites of covalent-binding.
Collapse
Affiliation(s)
- M Coulet
- INRA, Laboratoire de Pharmacologie-Toxicologie, 180 Chemin de Tournefeuille BP3, 31931, Toulouse, France
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Calléja C, Bigot K, Eeckhoutte C, Sibille P, Boulard C, Galtier P. Comparison of hepatic and renal drug-metabolising enzyme activities in sheep given single or two-fold challenge infections with Fasciola hepatica. Int J Parasitol 2000; 30:953-8. [PMID: 10927086 DOI: 10.1016/s0020-7519(00)00070-9] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
The activity of drug-metabolising enzymes was compared in liver and kidneys of adult sheep given single or two-fold fluke infection. Fascioliasis was induced by oral administration of 200 metacercariae of Fasciola hepatica to female sheep either 10 or 20 weeks (mono-infections) or 10 and 20 weeks (bi-infection) before killing. The parasitic pathology was ascertained at autopsy and by clinical observation of animals. In the liver of both mono- and bi-infected animals, significant decreases (P<0.05) (17-44%) were observed in the microsomal content of cytochrome P450 and in the two measured P450-dependent monooxygenase activities, benzphetamine and ethylmorphine N-demethylations. Moreover, Western blot analysis of microsomes demonstrated a decrease in the expression of cytochrome P4503A subfamily correlative with that of its presumed corresponding activity ethylmorphine N-demethylase. By contrast, the conjugation of chloro-dinitrobenzene to glutathione remained unchanged in liver cytosolic fractions prepared from all these animals. In kidneys, a significant decrease (P<0.05) (30%) in microsomal cytochrome P450 level of 10-week mono-infected sheep was observed whereas there was no change in the other groups of animals. The inflammatory origin and the consequences in terms of pathology and animal productivity of the fascioliasis-induced decreases in tissue-oxidative drug metabolism are discussed, particularly in the case of adult sheep suffering repetitive infections.
Collapse
Affiliation(s)
- C Calléja
- Laboratoire de Pharmacologie-Toxicologie INRA, 180 Chemin de Tournefeuille, BP3, 31931, Toulouse, France
| | | | | | | | | | | |
Collapse
|
25
|
Sibille P, Calléja C, Carreras F, Bigot K, Galtier P, Boulard C. Fasciola hepatica: influence of gender and liver biotransformations on flukicide treatment efficacy of rats infested and cured with either clorsulon/ivermectin or triclabendazole. Exp Parasitol 2000; 94:227-37. [PMID: 10831390 DOI: 10.1006/expr.2000.4501] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Two fasciolicide preparations have been compared in 130 rats experimentally infected with Fasciola hepatica. Parasitological, immunological, and biochemical parameters have been followed to monitor the efficacy of the treatments. While Fascinex (triclabendazole) efficiently cured both male and female rats when administered as soon as 4 weeks postinfection, treatment with Ivomec-D (clorsulon + ivermectin) displayed a low efficacy on either male or female rats at this time point (54 and 0%, respectively). Moreover, when administered 8 weeks postinfection, the Ivomec-D treatment proved highly efficient on male rats while it displayed little effect on the female population (100 and 53%, respectively). This unexpected result has been related to an overexpression of a P4503A isoform that is observed only in females that have been treated with Ivomec-D. The influence of this P4503A cytochrome on drug metabolism and the need for the incorporation of both genders in clinical trials are discussed.
Collapse
Affiliation(s)
- P Sibille
- Station de Pathologie Aviaire et Parasitologie, INRA, Nouzilly, 37380, France
| | | | | | | | | | | |
Collapse
|
26
|
Lifschitz A, Virkel G, Sallovitz J, Sutra JF, Galtier P, Alvinerie M, Lanusse C. Comparative distribution of ivermectin and doramectin to parasite location tissues in cattle. Vet Parasitol 2000; 87:327-38. [PMID: 10669102 DOI: 10.1016/s0304-4017(99)00175-2] [Citation(s) in RCA: 132] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Pharmacokinetic studies have been used traditionally to characterize drug concentration profiles achieved in the bloodstream. However, endectocide molecules exert their persistent and broad spectrum activity against parasites localized in many different tissues. The aim of this study was to compare the distribution of ivermectin (IVM) and doramectin (DRM) to different tissues in which parasites are found following subcutaneous administration to calves. Holstein calves weighing 120-140 kg were injected in the shoulder area with commercially available formulations of IVM (Ivomec 1% MSD AGVET, NJ, USA) (Group A) or DRM (Dectomax 1%, Pfizer, NY, USA) (Group B). Two treated calves were sacrificed at 1, 4, 8, 18, 28, 38, 48 or 58 days post-treatment. Plasma, abomasal and small intestinal fluids and mucosal tissues, bile, faeces, lung and skin samples were collected, extracted, derivatized and analyzed by high performance liquid chromatography (HPLC) with fluorescence detection to determine IVM and DRM concentrations. IVM and DRM were distributed to all the tissues and fluids analyzed. Concentrations >0.1 ng/ml (ng/g) were detected between 1 and 48 days post-treatment in all the tissues and fluids investigated. At 58 days post-treatment, IVM and DRM were detected only in bile and faeces, where large concentrations were excreted. Delayed Tmax values for DRM (4 days post-administration) compared to those for IVM (1 day) were observed in the different tissues and fluids. High IVM and DRM concentrations were measured in the most important target tissues, including skin. The highest IVM and DRM concentrations were measured in abomasal mucosa and lung tissue. Enhanced availabilities of both IVM (between 45 and 244%) and DRM (20-147%) were obtained in tissues compared to plasma. There was good correlation between concentration profiles of both compounds in plasma and target tissues (mucosal tissue, skin, and lung). Drug concentrations in target tissues remained above 1 ng/g for either 18 (IVM) or 38 (DRM) days post-treatment. The characterization of tissue distribution patterns contributes to our understanding of the basis for the broad-spectrum endectocide activity of avermectin-type compounds.
Collapse
Affiliation(s)
- A Lifschitz
- Departamento de Fisiopatología, Facultad de Ciencias Veterinarias, Universidad Nacional del Centro, Tandil, Argentina.
| | | | | | | | | | | | | |
Collapse
|
27
|
Guerre P, Pineau T, Costet P, Burgat V, Galtier P. Effects of AFB1 on CYP 1A1, 1A2 and 3A6 mRNA, and P450 expression in primary culture of rabbit hepatocytes. Toxicol Lett 2000; 111:243-51. [PMID: 10643869 DOI: 10.1016/s0378-4274(99)00181-2] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
Although numerous studies report strong hepatic cytochrome P450 decrease during aflatoxicosis, the mechanisms involved in this decrease remain to be established. The purpose of this work is to investigate whether decreased CYP mRNA expression could explain decreased P450 expression and activity. Studies were conducted in primary cultures of rabbit hepatocytes exposed to 0.1 and 1 microM aflatoxin B1 (AFB1) incubated in the culture medium for 72 h. In order to confirm the effects of the mycotoxin, 30 microM beta-naphthoflavone or rifampicin were used as respective inductors of P450 1A1 and 1A2 or 3A6. Dose-dependent decreases of CYP mRNA expression were observed in all AFB1-treated cells; however, these decreases were not specific. Moreover, P450 expression and activity are far less decreased by the AFB1 treatment than their corresponding mRNA. Taken together, these results suggest that the specific P450 decrease observed during aflatoxicosis was not the consequence of a specific decrease of their mRNA expression.
Collapse
Affiliation(s)
- P Guerre
- Département des Sciences Biologiques et Fonctionnelles, Pharmacie-Toxicologie, ENVT, Toulouse, France
| | | | | | | | | |
Collapse
|
28
|
Alvinerie M, Sutra JF, Galtier P, Mage C. Pharmacokinetics of eprinomectin in plasma and milk following topical administration to lactating dairy cattle. Res Vet Sci 1999; 67:229-32. [PMID: 10607502 DOI: 10.1053/rvsc.1999.0312] [Citation(s) in RCA: 81] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
The pharmacokinetics and mammary excretion of eprinomectin were determined in cattle following topical administration at a dose rate of 0.5 mg kg(-1). The kinetics of plasma and milk concentrations were analysed using a one-compartment model. The maximum plasma concentration of 43.76 ng ml(-1)occurred 2.02 days post administration, and the mean residence time was 4.16 days. Eprinomection was detected in the milk at the first sampling time and thereafter for at least 15 days. Comparison of the milk and plasma data demonstrated the parallel disposition of the drug in the milk and plasma with a milk / plasma concentration ratio of 0. 102+/-0.048. The amount of drug recovered in the milk during this period was 0.109% +/- 0.038 of the total administered dose. This very low extent of mammary excretion resulted in low concentrations of eprinomectin in milk. This supports the permitted use in lactating cattle, as the maximum level of residue in milk did not exceed the maximum acceptable limit of 30 ng ml(-1).
Collapse
Affiliation(s)
- M Alvinerie
- Laboratoire de Pharmacologie-Toxicologie, INRA, BP3, Toulouse Cedex 9, 31931, USA
| | | | | | | |
Collapse
|
29
|
Abstract
The pharmacokinetic behaviour of doramectin after a single subcutaneous administration and moxidectin following a single subcutaneous or oral drench were studied in goats at a dosage of 0.2 mg kg(-1). The drug plasma concentration-time data were analysed by compartmental pharmacokinetics and non-compartmental methods. Maximum plasma concentrations of moxidectin were attained earlier and to a greater extent than doramectin (shorter t(max) and greater C(max) and AUC than doramectin). MRT of doramectin (4.91 +/- 0.07 days) was also significantly shorter than that of moxidectin (12.43 +/- 1.28 days). Then, the exposure of animals to doramectin in comparison with moxidectin was significantly shorter. The apparent absorption rate of moxidectin was not significantly different after oral and subcutaneous administration but the extent of absorption, reflected in the peak concentration (C(max)) and the area under the concentration-time curve (AUC), of the subcutaneous injection (24.27 +/- 1.99 ng ml(-1) and 136.72 +/- 7.35 ng d ml(-1) respectively) was significantly greater than that of the oral administration (15.53 +/- 1.27 ng ml(-1) and 36.72 +/- 4.05 ng d ml(-1) respectively). The mean residence time (MRT) of moxidectin didn't differ significantly when administered orally or subcutaneously. Therefore low oral bioavailability and the early emergence of resistance in this minor species may be related. These results deserve to be correlated with efficacy studies for refining dosage requirements of endectocides in this species.
Collapse
Affiliation(s)
- E Escudero
- Departamento de Ciencias Socio-Sanitarias, Facultad de Veterinaria, Universidad de Murcia, Campus de Espinardo, Murcia, 30.071, Spain
| | | | | | | | | | | |
Collapse
|
30
|
Lifschitz A, Virkel G, Imperiale F, Sutra JF, Galtier P, Lanusse C, Alvinerie M. Moxidectin in cattle: correlation between plasma and target tissues disposition. J Vet Pharmacol Ther 1999; 22:266-73. [PMID: 10499239 DOI: 10.1046/j.1365-2885.1999.00222.x] [Citation(s) in RCA: 55] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
The time of parasite exposure to active drug concentrations determines the persistence of the antiparasitic activity of endectocide compounds. This study evaluates the disposition kinetics of moxidectin (MXD) in plasma and in different target tissues following its subcutaneous (s.c.) administration to cattle. Eighteen male, 10-month old Holstein calves weighing 120-140 kg were subcutaneously injected in the shoulder area with a commercially available formulation of MXD (Cydectin 1%, American Cyanamid, Wayne, NJ, USA) at 200 micrograms/kg. Two treated calves were killed at each of the following times post-treatment: 1, 4, 8, 18, 28, 38, 48, 58 and 68 days. Abomasal and small intestine mucosal tissue and fluids, bile, faeces, lung, skin and plasma samples were collected, extracted, derivatized and analysed to determine MXD concentrations by high performance liquid chromatography (HPLC) with fluorescence detection. MXD was extensively distributed to all tissues and fluids analysed, being detected (concentrations > 0.1 ng/g; ng/mL) between 1 and 58 days post-treatment. MXD peak concentrations were attained during the first sampling day. MXD maximum concentration (Cmax) values ranged from 52.9 (intestinal mucosa) up to 149 ng/g (faeces). The mean residence time (MRT) in the different tissues and fluids ranged from 6.8 (abomasal mucosa) up to 11.3 (bile) days. MXD concentrations in abomasal and intestinal mucosal tissue were higher than those detected in plasma; however, there was a high correlation between MXD concentrations observed in plasma and those detected in both gastrointestinal mucosal tissues. MXD concentrations were markedly greater in the mucosa than in its respective digestive fluid (P < 0.01). MXD concentrations in skin were higher than those found in plasma (P < 0.01). Drug concentrations recovered in the dermis were greater than those detected in the hypodermal tissue (P < 0.05). Large concentrations of MXD were excreted in bile and faeces. These findings may contribute to an understanding of the relationship between the kinetic behaviour and the persistence of the antiparasite activity of MXD against different ecto-endoparasites in cattle.
Collapse
Affiliation(s)
- A Lifschitz
- Departamento de Fisiopatología, Facultad de Ciencias Veterinarias, Universidad Nacional del Centro, Tandil, Argentina
| | | | | | | | | | | | | |
Collapse
|
31
|
|
32
|
Pérez R, Cabezas I, García M, Rubilar L, Sutra JF, Galtier P, Alvinerie M. Comparison of the pharmacokinetics of moxidectin (Equest) and ivermectin (Eqvalan) in horses. J Vet Pharmacol Ther 1999; 22:174-80. [PMID: 10447828 DOI: 10.1046/j.1365-2885.1999.00200.x] [Citation(s) in RCA: 47] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
A study was undertaken in order to evaluate and compare plasma disposition kinetic parameters of moxidectin and ivermectin after oral administration of their commercially available preparations in horses. Ten clinically healthy adult horses, weighing 390-446 kg body weight (b.w.), were allocated to two experimental groups of five horses. Group I was treated with an oral gel formulation of moxidectin (MXD) at the manufacturers recommended therapeutic dose of 0.4 mg/kg bw. Group II was treated with an oral paste formulation of ivermectin (IVM) at the manufacturers recommended dose of 0.2 mg/kg b.w. Blood samples were collected by jugular puncture at different times between 0.5 h and 75 days post-treatment. After plasma extraction and derivatization, samples were analysed by HPLC with fluorescence detection. Computerized kinetic analysis was carried out. The parent molecules were detected in plasma between 30 min and either 30 (IVM) or 75 (MXD) days post-treatment. Both drugs showed similar patterns of absorption and no significant difference was found for the time corresponding to peak plasma concentrations or for absorption half-life. Peak plasma concentrations (Cmax) of 70.3+/-10.7 ng/mL (mean +/- SD) were obtained for MXD and 44.0+/-23.1 ng/mL for IVM. Moreover, the values for area under concentration-time curve (AUC) were 363.6+/-66.0 ng x d/mL for the MXD treated group, and 132.7+/-47.3 ng x d/mL for the IVM treated group. The mean plasma residence times (MRT) were 18.4+/-4.4 and 4.8+/-0.6 days for MXD and IVM treated groups, respectively. The results showed a more prolonged residence of MXD in horses as demonstrated by a four-fold longer MRT than for IVM. The longer residence and the higher concentrations found for MXD in comparison to IVM could possibly explain a more prolonged anthelmintic effect. It is concluded that in horses the commercial preparation of MXD presents a pharmacokinetic profile which differs significantly from that found for a commercial preparation of IVM. To some extent these results likely reflect differences in formulation and doses.
Collapse
Affiliation(s)
- R Pérez
- Laboratorio de Farmacología, Facultad Medicina Veterinaria, Universidad de Concepción, Chillán, Chile
| | | | | | | | | | | | | |
Collapse
|
33
|
Alvinerie M, Sutra JF, Galtier P, Lifschitz A, Virkel G, Sallovitz J, Lanusse C. Persistence of ivermectin in plasma and faeces following administration of a sustained-release bolus to cattle. Res Vet Sci 1999; 66:57-61. [PMID: 10088713 DOI: 10.1053/rvsc.1998.0240] [Citation(s) in RCA: 46] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Six calves (weight 210 to 230 kg) were dosed with an intra-ruminal slow-release bolus prepared to deliver ivermectin at a low daily dosage for 135 days. Ivermectin concentrations in jugular blood 160 days post-treatment were determined by high performance liquid chromatography (HPLC) using fluorescence detection. Ivermectin plasma concentrations increased gradually to achieve the steady-state concentration (20 ng ml(-1)) at approximately four days post-treatment, which was maintained for 120 days. The ivermectin peak plasma concentration (28.5 ng ml(-1)) was attained at 15 days post-administration of the bolus. The faecal ivermectin concentration rose to a maximal concentration of 4.1 microg g(-1) at four days post-treatment, dropping to a steady-state concentration of around 1.18 microg g(-1) which was maintained up to 120 days post-treatment. Ivermectin was detected in both plasma (0.05 ng ml(-1)) and faeces (2.67 ng g(-1)) up to 160 days. The high levels of ivermectin recovered in faeces indicate that a large proportion of the dose released by the bolus (80 to 90 per cent) is excreted in faeces.
Collapse
Affiliation(s)
- M Alvinerie
- Laboratoire de Pharmacologie et Toxicologie, INRA, Toulouse, France
| | | | | | | | | | | | | |
Collapse
|
34
|
Guerre P, Larrieu G, Burgat V, Galtier P. Cytochrome P450 decreases are correlated to increased microsomal oxidative damage in rabbit liver and primary cultures of rabbit hepatocytes exposed to AFB1. Toxicol Lett 1999; 104:117-25. [PMID: 10048757 DOI: 10.1016/s0378-4274(98)00352-x] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Although numerous studies report hepatic drug metabolizing enzyme alterations during aflatoxicosis, the mechanisms involved in P450 decreases remain to be established. The purpose of this work is to investigate whether increased oxidative damage revealed by the detection of malondialdehyde (MDA), lipofuscin substances, and conjugated dienes in microsomes, could explain the decreased P450 content. Studies were conducted with two different doses of aflatoxin B1 (AFB1), both in vivo in rabbits and ex vivo in primary cultures of rabbit hepatocytes, in the presence or absence of beta-naphthoflavone or rifampicin used as respective P450 inducers. Strong negative correlations were observed between MDA and P450 contents, both in vivo and ex vivo, whereas rifampicin appears to protect the hepatocytes from oxidative damage but not AFB1 toxicity. Positive correlation were also obtained between MDA formation and lactate dehydrogenase (LDH), aspartate aminotransferase (ASAT) or alanine amino-transferase (ALAT) releases, used as non-specific markers of AFB1 toxicity. Taken together these results suggest that the dramatic decreases of cytochrome P450 observed in vivo during aflatoxicosis could be linked, at least in part, to microsomal oxidative damage.
Collapse
Affiliation(s)
- P Guerre
- Département des Sciences Biologiques et Fonctionnelles, Pharmacie-Toxicologie, E.N.V.T., Toulouse, France
| | | | | | | |
Collapse
|
35
|
Pineau T, Costet P, Puel O, Pfohl-Leszkowicz A, Lesca P, Alvinerie M, Galtier P. Knockout animals in toxicology: assessment of toxin bioactivation pathways using mice deficient in xenobiotic metabolizing enzymes. Toxicol Lett 1998; 102-103:459-64. [PMID: 10022296 DOI: 10.1016/s0378-4274(98)00339-7] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
Genetically engineered animal models represent a substantial improvement in in vivo assessment of toxic pathways. Several transgenic mouse lines have been designed to detect specific toxic markers in response to xenobiotic exposure. They are suitable for in vivo large scale screening of potentially toxic effects of drugs and other xenobiotics, and are used as bioassay models for carcinogenicity testing. This contribution will focus on a different strategy, using transgenic knockout mouse lines, to investigate with more accuracy some metabolic pathways leading to the bioactivation or the bioinactivation of xenobiotics. Through direct knockout of cytochrome P450 (CYP) genes or the knockout of the transcriptional activator of CYP genes AHR (aryl hydrocarbon receptor), the involvement of hepatic metabolic enzymes in xenobiotic bioactivation will be exemplified.
Collapse
Affiliation(s)
- T Pineau
- Laboratoire de Pharmacologie et Toxicologie, INRA, Toulouse, France
| | | | | | | | | | | | | |
Collapse
|
36
|
Calleja C, Eeckhoutte C, Dacasto M, Larrieu G, Dupuy J, Pineau T, Galtier P. Comparative effects of cytokines on constitutive and inducible expression of the gene encoding for the cytochrome P450 3A6 isoenzyme in cultured rabbit hepatocytes: consequences on progesterone 6beta-hydroxylation. Biochem Pharmacol 1998; 56:1279-85. [PMID: 9825726 DOI: 10.1016/s0006-2952(98)00178-6] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
Cultured rabbit hepatocytes were used to compare the relative activities of cytokines to inhibit the constitutive or rifampicin (RIF)-induced expression of the cytochrome P450 3A6 gene (CYP3A6). Human recombinant cytokines tested were interleukin-1beta (IL-1beta) (2 U/mL), interleukin-2 (IL-2) (5,000 U/mL) and interferon-gamma (IFN-gamma) (50 U/mL). Hepatocytes were cultured in the presence or absence of 25 microM RIF for 24 hr, with or without cytokines alone or in combination. All these cytokines inhibited RIF-induced P4503A6 expression without apparent cellular toxicity. By contrast, only IFN-gamma treatment provided a significant decrease (41%) in the constitutive P4503A6 protein level. Moreover, cytokines differed in their ability to repress RIF-dependent transcriptional induction of CYP3A6: IL-1beta and IL-2 were approximately equipotent, causing an almost 40-50% suppression of CYP3A6 mRNA and protein levels, whereas IFN-gamma exerted repressive effects only on P4503A6-related erythromycin N-demethylase activity and inducible protein expression. In fact, although strongly reducing P4503A6 protein content (an approximate 70% decrease), IFN-gamma did not exhibit any influence on CYP3A6 mRNAs with the exception of its association with interleukins. All these results suggest that IL-1beta and IL-2 mainly promote a transcriptional repression mechanism, given the absence of effect of these cytokines on the basal P4503A6 level, whereas IFN-gamma exerts a post-transcriptional suppressive action on both induced and constitutive P4503A6 expression. Consequently, P4503A6-dependent progesterone 6beta-hydroxylase activity also presented a cytokine-specific pattern of inhibition, with a much greater sensitivity than P4503A6 immunoreactive protein to IL-1beta and IL-2 + IFN-gamma treatments. Thus, this study underlines the significant impact of inflammation on steroid metabolism.
Collapse
Affiliation(s)
- C Calleja
- Laboratoire de Pharmacologie-Toxicologie INRA, Toulouse, France
| | | | | | | | | | | | | |
Collapse
|
37
|
Costet P, Legendre C, Moré J, Edgar A, Galtier P, Pineau T. Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis. J Biol Chem 1998; 273:29577-85. [PMID: 9792666 DOI: 10.1074/jbc.273.45.29577] [Citation(s) in RCA: 332] [Impact Index Per Article: 12.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023] Open
Abstract
The alpha-isoform of the peroxisome proliferator-activated receptor (PPARalpha) is a nuclear transcription factor activated by structurally diverse chemicals referred to as peroxisome proliferators. Activators can be endogenous molecules (fatty acids/steroids) or xenobiotics (fibrate lipid-lowering drugs). Upon pharmacological activation, PPARalpha modulates target genes encoding lipid metabolism enzymes, lipid transporters, or apolipoproteins, suggesting a role in lipid homeostasis. Transgenic mice deficient in PPARalpha were shown to lack hepatic peroxisomal proliferation and have an impaired expression and induction of several hepatic target genes. Young adult males show hypercholesterolemia but normal triglycerides. Using a long term experimental set up, we identified these mice as a model of monogenic, spontaneous, late onset obesity with stable caloric intake and a marked sexual dimorphism. Serum triglycerides, elevated in aged animals, are higher in females that develop a more pronounced obesity than males. The latter show a marked and original centrilobular-restricted steatosis and a delayed occurrence of obesity. Fat cells from their liver express substantial levels of PPARgamma2 transcripts when compared with lean cells. These studies demonstrate, in rodents, the involvement of PPARalpha nuclear receptor in lipid homeostasis, with a sexually dimorphic control of circulating lipids, fat storage, and obesity. Characterization of this pathological link may help to delineate new molecular targets for therapeutic intervention and could lead to new insights into the etiology and heritability of mammalian obesity.
Collapse
Affiliation(s)
- P Costet
- Laboratoire de Pharmacologie et Toxicologie, INRA, BP 3, 31931 Toulouse, Cedex 09 France
| | | | | | | | | | | |
Collapse
|
38
|
|
39
|
Sutra JF, Chartier C, Galtier P, Alvinerie M. Determination of eprinomectin in plasma by high-performance liquid chromatography with automated solid phase extraction and fluorescence detection. Analyst 1998; 123:1525-7. [PMID: 9830164 DOI: 10.1039/a802093k] [Citation(s) in RCA: 24] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A method is described for the determination of eprinomectin in plasma using high-performance liquid chromatography with fluorescence detection (excitation and emission wavelengths 355 and 465 nm, respectively). The fluorescent derivative was obtained by a condensation reaction with trifluoroacetic anhydride and N-methylimidazole. The method employs 1 ml plasma samples and gives linear calibration graphs (r = 0.999) over the concentration range studied (0.5-50 ng ml-1). Solid extraction using the benchmate procedure was used for sample preparation. This method permits the determination of eprinomectin at levels as low as 0.1 ng ml-1 and is suitable for the pharmacokinetic study of eprinomectin in animals.
Collapse
Affiliation(s)
- J F Sutra
- Laboratoire de Pharmacologie-Toxicologie, INRA, Toulouse, France
| | | | | | | |
Collapse
|
40
|
Pineau T, Costet P, Puel O, Leszckowicz A, Lesca P, Alvinerie M, Galtier P. Knockout animals in toxicology: Assessment of toxin bioactivation pathways using mice deficient in xenobiotic metabolizing enzymes. Toxicol Lett 1998. [DOI: 10.1016/s0378-4274(98)80090-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
41
|
Coulet M, Dacasto M, Eeckhoutte C, Larrieu G, Sutra JF, Alvinerie M, Macé K, Pfeifer AM, Galtier P. Identification of human and rabbit cytochromes P450 1A2 as major isoforms involved in thiabendazole 5-hydroxylation. Fundam Clin Pharmacol 1998; 12:225-35. [PMID: 9565779 DOI: 10.1111/j.1472-8206.1998.tb00946.x] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
This report characterized one of the major cytochrome P450 isozyme involved in thiabendazole metabolism. This study was undertaken by using both cultured rabbit hepatocytes treated or not with drugs known to specifically induced various cytochromes P450 isoenzymes (i.e., P450 1A1/2 by beta-naphthoflavone, P450 2B4 by phenobarbital, P450 3A6 by rifampicine and P450 4A by clofibrate) and human liver (THLE-5) and bronchial (BEAS-2B) epithelial cells expressing or not the major constitutive human cytochromes P450 (i.e., CYP1A2, 2A6, 2B6, 2C9, 2D6, 2E1 or 3A4). Only hepatocytes exposed to beta-naphthoflavone and clofibrate significantly metabolized thiabendazole to 5-hydroxythiabendazole. Extensive biotransformation of this anthelmintic only occurred in human cells expressing CYP1A2. Moreover, experiments performed on rabbit preparations showed good correlations between thiabendazole 5-hydroxylase activity and both ethoxyresorufin and methoxyresorufin O-dealkylase activities. Thus, CYP1A2 is a major isoenzyme involved in thiabendazole 5-hydroxylation.
Collapse
Affiliation(s)
- M Coulet
- INRA, Laboratoire de Pharmacologie-Toxicologie, Toulouse, France
| | | | | | | | | | | | | | | | | |
Collapse
|
42
|
Alvinerie M, Escudero E, Sutra JF, Eeckhoutte C, Galtier P. The pharmacokinetics of moxidectin after oral and subcutaneous administration to sheep. Vet Res 1998; 29:113-8. [PMID: 9601143] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Abstract
The pharmacokinetic parameters of moxidectin were determined in ten sheep following a single subcutaneous or oral drench at a dose of 0.2 mg.kg-1. The plasma kinetics were best fitted by a two-compartment model. Moxidectin was detected in the plasma at the first sampling time (1 h) and thereafter for at least 60 d. The AUC were similar after both treatments indicating the same bioavailability for the two routes of administration. The oral route was characterized by a higher Cmax value (28.07 ng.mL-1 than after subcutaneous injection (8.29 ng.mL-1 and by significantly faster absorption as indicated by Tmax of 0.22 d and 0.88 d for oral and subcutaneous administrations, respectively. The most striking result of this experiment was the longer mean residence time reported for the subcutaneous route, i.e. 16.80 d as compared to 12.55 d for the oral drench. This differences is in agreement with previous studies demonstrating the longer anthelmintic efficacy of the subcutaneous route in comparison with oral administration.
Collapse
Affiliation(s)
- M Alvinerie
- Laboratoire de pharmacologie-toxicologie, Inra, Toulouse, France.
| | | | | | | | | |
Collapse
|
43
|
Coulet M, Eeckhoutte C, Larrieu G, Sutra JF, Hoogenboom LA, Huveneers-Oorsprong MB, Kuiper HA, Castell JV, Alvinerie M, Galtier P. Comparative Metabolism of Thiabendazole in Cultured Hepatocytes from Rats, Rabbits, Calves, Pigs, and Sheep, Including the Formation of Protein-Bound Residues. J Agric Food Chem 1998; 46:742-748. [PMID: 10554308 DOI: 10.1021/jf970580s] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
Cultured hepatocytes from rat, rabbit, calf, pig, and sheep were used to study metabolism and formation of protein-bound residues of thiabendazole ([(14)C]TBZ), a benzimidazole anthelmintic and fungicide. In all investigated species, major pathways corresponded to 5-hydroxylation of TBZ and its further conjugation. However, marked interspecies differences in rates of TBZ disappearance and 5-hydroxy metabolite formation were demonstrated. Rabbit hepatocytes presented the fastest TBZ biotransformation and were the most extensive hydroxylators. By contrast, the lowest capacity of oxidation was observed for the rat. Two unidentified minor metabolites, designated M1 and M2, were particularly produced by sheep hepatocytes. Moreover, the protein-bound residues in these cells, which could be related to cytochrome P450-dependent oxidation, were formed in 4 times greater amounts than in the other animal cells. These findings substantiate hepatocytes as an in vitro model for prediction of hepatic metabolism in vivo.
Collapse
Affiliation(s)
- M Coulet
- INRA, Laboratoire de Pharmacologie-Toxicologie, 180 Chemin de Tournefeuille, B.P. 3, 31931 Toulouse, France; State Institute for Quality Control of Agricultural Products (RIKILT-DLO), P.O. Box 230, 6700 AE Wageningen, The Netherlands; and Unidad de Hepatologia Experimental, Centro de Investigacion, Hospital La Fe, SVS Avenida Campanar 21, E-46009 Valencia, Spain
| | | | | | | | | | | | | | | | | | | |
Collapse
|
44
|
Foussat J, Costet P, Galtier P, Pineau T, Lesca P. The 4S benzo(a)pyrene-binding protein is not a transcriptional activator of Cyp1a1 gene in Ah receptor-deficient (AHR -/-) transgenic mice. Arch Biochem Biophys 1998; 349:349-55. [PMID: 9448724 DOI: 10.1006/abbi.1997.0465] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
In an effort to better understand the role of the 4S benzo(a)pyrene-binding protein in the induction of CYP1A1 by PAHs, we used a genetically engineered mouse line deficient in Ah receptor (AHR -/-). First, we demonstrated through binding experiments analyzed by sucrose gradient sedimentation and gel permeation chromatography that AHR -/- mice have no detectable AHR protein. In contrast, this AHR-deficient line expressed a 4S protein which efficiently binds BP as it does in hepatic cytosol from C57BL/6 mice. In vivo BP exposure in AHR-deficient mice proved the inability to sustain any CYP1A1 mRNA or CYP1A1 protein induction. These findings demonstrate the requirement of an active AHR to sustain the transactivation pathway leading to CYP1A1 induction. Surprisingly, the 4S BP-binding protein, which was previously characterized as the glycine N-methyltransferase, was completely devoid of such an enzymatic activity after purification by Sephacryl gel permeation chromatography. Moreover, sedimentation and chromatographic experiments, under nondenaturing conditions, do not support the assumption of 4S protein as a subunit of a multimeric protein (GNMT) displaying a molecular mass of 150 kDa.
Collapse
Affiliation(s)
- J Foussat
- Laboratoire de Pharmacologie et Toxicologie, Institut National de la Recherche Agronomique, Toulouse, France
| | | | | | | | | |
Collapse
|
45
|
Lesca P, Pineau T, Galtier P, Peryt B, Derancourt J. The 8S benzo(a)pyrene-binding protein is an aldehyde dehydrogenase regulated by the Ah receptor. Biochem Biophys Res Commun 1998; 242:26-31. [PMID: 9439604 DOI: 10.1006/bbrc.1997.7901] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
8S Benzo(a)pyrene-binding proteins from liver cytosol of mouse and rabbit have been partially purified by gel permeation chromatography and affinity chromatography on 1-aminopyrene-Sepharose columns. These proteins, which bind polycyclic aromatic hydrocarbons and daunorubicine, have been identified, by microsequencing, as aldehyde dehydrogenases composed of polypeptides of 54 kDa. Using Ah receptor-deficient (AHR-/-) transgenic mice it has been shown that the amount as well as the binding capabilities of 8S protein was strongly altered in these mice, suggesting that its expression was partially under the control of the Ah receptor. The function of these proteins is currently unknown.
Collapse
Affiliation(s)
- P Lesca
- Laboratoire de Pharmacologie-Toxicologie, INRA, Toulouse, France
| | | | | | | | | |
Collapse
|
46
|
Abstract
The purpose of this study was to determine the influence of aflatoxin B1 (AFB1), incubated in vitro with rabbit liver microsomes, on some cytochrome P450-dependent monooxygenases activities. A strong competitive inhibition of the mycotoxin on aniline hydroxylation was observed. The concentration which provoked a 50% inhibition (IC50) was around 20 microM, whereas a Ki of 3 microM was determined. In contrast, only weak inhibitions of both pentoxyresorufin and ethoxyresorufin O-dealkylases (PROD and EROD) activities were obtained. They were characterized by respective IC50 of 200 and 260 microM. The inhibition was 'non competitive' for PROD activity and 'mixed' for EROD. The Ki of the reactions were respectively 177 and 510 microM. Considering the fact that AFB1 has been previously reported to decrease microsomal hepatic cytochrome P450 expression, the results obtained in this study strengthen the hypothesis that the normal metabolism of xenobiotics by the liver could be altered in AFB1 exposure.
Collapse
Affiliation(s)
- P Guerre
- Département des Sciences Biologíques et Fonctionnelles, Pharmacie-Toxicologie, E.N.V.T., Toulouse, France
| | | | | | | |
Collapse
|
47
|
Calleja C, Eeckhoutte C, Larrieu G, Dupuy J, Pineau T, Galtier P. Differential effects of interleukin-1 beta, interleukin-2, and interferon-gamma on the inducible expression of CYP 1A1 and CYP 1A2 in cultured rabbit hepatocytes. Biochem Biophys Res Commun 1997; 239:273-8. [PMID: 9345309 DOI: 10.1006/bbrc.1997.7468] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
The effects of interleukin-1 beta, interleukin-2 and interferon-gamma and their combinations were investigated on induced cytochrome P 4501A of cultured rabbit hepatocytes considered 72 h after plating. Without apparent cellular toxicity, these cytokines provoke a significant decrease in TBZ- and BNF-induced P4501A1/ 2 expression. However specific patterns of action are revealed: IL-1 beta is the most potent cytokine in regard to CYP1A1/2 mRNA suppression whereas IL-2 exerts repressive effects only on P4501A1 induced expression. Although being a strong inhibitor of induced enzymatic activities and protein contents, IFN-gamma exhibits only a weak influence on CYP1A1/2 mRNAs with the exception of its association with interleukins. All these results suggest that IL-1 beta and IL-2 promote mainly transcriptional repression mechanism whereas IFN-gamma would stimulate a post-transcriptional suppressive pathway.
Collapse
Affiliation(s)
- C Calleja
- Laboratoire de Pharmacologie-Toxicologie INRA, Toulouse, France
| | | | | | | | | | | |
Collapse
|
48
|
Abstract
Aflatoxin B1 (AFB1) has been reported to decrease microsomal hepatic cytochrome P450 (P450) content and increase both total plasma bilirubin concentration and liver heme oxygenase activity. The purposes of this study were to determine whether liver hemoproteins contents and heme catabolizing enzymes were affected by the mycotoxin and whether these alterations were linked to hyperbilirubinemia. Male New Zealand rabbits were divided into three groups of five animals, each receiving for 5 days either arabic gum as vehicle or AFB1 at a daily oral dose of 0.05 or 0.10 mg/kg. These treatments affected neither cytochrome b5 content nor NADPH-cytochrome reductase activity. A linear dose-dependent decrease in cytochrome P450 content and increases in both heme oxygenase and biliverdin reductase activities were observed. Bilirubin UDP-glucuronyltransferase activity was dramatically decreased at both doses, whereas cholestasis occurred only at 0.10 mg/kg. An exponential dose-dependent increase in plasma bilirubin concentration was also observed. Both the simultaneous exponential increase in bilirubinemia associated to a reduced bilirubin UDP-glucuronyltransferase activity and the absence of cholestasis at 0.05 mg/kg, suggested that the hyperbilirubinemia is more probably related to an increased heme catabolism than to an altered bile duct permeability.
Collapse
Affiliation(s)
- P Guerre
- Département des Sciences Biologiques et Fonctionnelles, Pharmacie-Toxicologie, E.N.V.T., Toulouse, France
| | | | | |
Collapse
|
49
|
Lanusse C, Lifschitz A, Virkel G, Alvarez L, Sánchez S, Sutra JF, Galtier P, Alvinerie M. Comparative plasma disposition kinetics of ivermectin, moxidectin and doramectin in cattle. J Vet Pharmacol Ther 1997; 20:91-9. [PMID: 9131534 DOI: 10.1046/j.1365-2885.1997.00825.x] [Citation(s) in RCA: 173] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
The persistence of the broad-spectrum antiparasitic activity of endectocide compounds relies on their disposition kinetics and pattern of plasma/tissues exchange in the host. This study evaluates the comparative plasma disposition kinetics of ivermectin (IVM), moxidectin (MXD) and doramectin (DRM) in cattle treated with commercially available injectable formulations. Twelve (12) parasite-free male Hereford calves (180-210 kg) grazing on pasture were allocated into three groups of four animals each. Animals in each group received either IVM (Ivomec 1%, MSD AGVET, Rahway, NJ, USA), MXD (Cydectin 1%. American Cyanamid, Wayne, NJ, USA) or DRM (Dectomax 1%, Pfizer Inc., New York, NY, USA) by subcutaneous injection at a dose of 200 micrograms/kg. Jugular blood samples were collected from 1 h up to 80 days post-treatment, and plasma extracted, derivatized and analysed by high performance liquid chromatography (HPLC) using fluorescence detection. The parent molecules were detected in plasma between 1 h and either 70 (DRM) or 80 (IVM and MXD) days post-treatment. The absorption of MXD from the site of injection was significantly faster (absorption half-life (t1/2ab) = 1.32 h) than those of IVM (t1/2ab = 39.2 h) and DRM (t1/2ab = 56.4 h). MXD peak plasma concentration (Cmax) was reached significantly earlier (8.00 h) compared to those of IVM and DRM (4-6 days post-treatment). There were no differences on Cmax values: the area under the concentration-time curve (AUC) was higher for IVM (459 ng.d/mL) and DRM (627 ng.d/mL) compared to that of MXD (217 ng.d/mL). The mean plasma residence time was longer for MXD (14.6 d) compared to IVM (7.35 d) and DRM (9.09 d). Unidentified metabolites were detected in plasma: they accounted for 5.75% (DRM), 8.50% (IVM) and 13.8% (MXD) of the total amount of their respective parent drugs recovered in plasma. The comparative plasma disposition kinetics of IVM, MXD and DRM in cattle, characterized over 80 days post-treatment under standardized experimental conditions, is reported for the first time.
Collapse
Affiliation(s)
- C Lanusse
- Departamento de Fisiopatología, Facultad de Ciencias Veterinarias, Universidad Nacional del Centro, Tandil, Argentina
| | | | | | | | | | | | | | | |
Collapse
|
50
|
Affiliation(s)
- M Oukessou
- Département de Physiologie et Thérapeutique, Institut Agro-Vétérinaire Hassan II, Rabat, Morocco
| | | | | | | | | |
Collapse
|